13F HOLDINGS REPORT
Samsara BioCapital, LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001104659-23-060814
Total Value
$485.8M
Positions
56
Other Managers
0
Confidential Omitted
No
Holdings (56)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CHINOOK THERAPEUTICS INC | 16961L106 | 5,161,888 | $119.5M | 24.60% |
| 2 | MINERALYS THERAPEUTICS INC | MLYS | 4,519,361 | $70.8M | 14.57% |
| 3 | SCHOLAR ROCK HLDG CORP | SRRK | 4,598,828 | $36.8M | 7.57% |
| 4 | ARCELLX INC | ACLX | 909,579 | $28.0M | 5.77% |
| 5 | GRAPHITE BIO INC | 38870X104 | 8,459,314 | $20.7M | 4.27% |
| 6 | RAIN ONCOLOGY INC | 75082Q105 | 2,260,652 | $19.8M | 4.07% |
| 7 | IVERIC BIO INC | 46583P102 | 686,835 | $16.7M | 3.44% |
| 8 | ZYMEWORKS INC | ZYME | 1,620,687 | $14.7M | 3.02% |
| 9 | VERONA PHARMA PLC | 925050106 | 695,001 | $14.0M | 2.87% |
| 10 | AVADEL PHARMACEUTICALS PLC | 05337M104 | 1,409,409 | $12.9M | 2.66% |
| 11 | NKARTA INC | NKTX | 2,868,035 | $10.2M | 2.10% |
| 12 | HILLEVAX INC | 43157M102 | 609,862 | $10.1M | 2.08% |
| 13 | INTERCEPT PHARMACEUTICALS IN | INTR | 640,688 | $8.6M | 1.77% |
| 14 | PEPGEN INC | PEPG | 651,050 | $8.0M | 1.64% |
| 15 | SUTRO BIOPHARMA INC | STRO | 1,675,579 | $7.7M | 1.59% |
| 16 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,693,736 | $6.5M | 1.34% |
| 17 | RHYTHM PHARMACEUTICALS INC | RYTM | 345,293 | $6.2M | 1.27% |
| 18 | DICE THERAPEUTICS INC | 23345J104 | 202,773 | $5.8M | 1.20% |
| 19 | PRIME MEDICINE INC | PRME | 470,304 | $5.8M | 1.19% |
| 20 | ACLARIS THERAPEUTICS INC | ACRS | 696,171 | $5.6M | 1.16% |
| 21 | AMRYT PHARMA PLC | 03217L106 | 304,715 | $4.4M | 0.91% |
| 22 | JANUX THERAPEUTICS INC | JANX | 360,414 | $4.4M | 0.90% |
| 23 | IMMUNOCORE HLDGS PLC | IMCR | 80,963 | $4.0M | 0.82% |
| 24 | ATYR PHARMA INC | ATYR | 1,750,000 | $3.7M | 0.76% |
| 25 | LYRA THERAPEUTICS INC | LYRA | 1,777,251 | $3.6M | 0.74% |
| 26 | IMMATICS N.V | IMTX | 495,000 | $3.4M | 0.70% |
| 27 | INOZYME PHARMA INC | 45790W108 | 504,407 | $2.9M | 0.59% |
| 28 | DAY ONE BIOPHARMACEUTICALS I | DAWN | 196,425 | $2.6M | 0.54% |
| 29 | TANGO THERAPEUTICS INC | TNGX | 630,000 | $2.5M | 0.51% |
| 30 | DECIBEL THERAPEUTICS INC | 24343R106 | 801,629 | $2.4M | 0.50% |
| 31 | TERNS PHARMACEUTICALS INC | TERN | 202,348 | $2.4M | 0.49% |
| 32 | SYROS PHARMACEUTICALS INC | 87184Q206 | 881,450 | $2.4M | 0.48% |
| 33 | LEAP THERAPEUTICS INC | 52187K101 | 6,693,038 | $2.3M | 0.47% |
| 34 | IGM BIOSCIENCES INC | 449585108 | 154,664 | $2.1M | 0.44% |
| 35 | IO BIOTECH INC | IOBT | 1,008,437 | $1.9M | 0.39% |
| 36 | ELEVATION ONCOLOGY INC | 28623U101 | 830,565 | $1.6M | 0.32% |
| 37 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,049,153 | $1.5M | 0.30% |
| 38 | EYEPOINT PHARMACEUTICALS INC | EYPT | 480,000 | $1.4M | 0.29% |
| 39 | VTV THERAPEUTICS INC | VTVT | 1,635,509 | $1.3M | 0.27% |
| 40 | ALX ONCOLOGY HLDGS INC | ALXO | 262,786 | $1.2M | 0.24% |
| 41 | INSTIL BIO INC | TIL | 1,788,280 | $1.2M | 0.24% |
| 42 | VIRACTA THERAPEUTICS INC | 92765F108 | 689,709 | $1.1M | 0.23% |
| 43 | ALLAKOS INC | 01671P100 | 172,089 | $765,796 | 0.16% |
| 44 | EQUILLIUM INC | EQ | 615,541 | $449,345 | 0.09% |
| 45 | ASTRIA THERAPEUTICS INC | 04635X102 | 25,000 | $332,500 | 0.07% |
| 46 | ALLOVIR INC | 019818103 | 82,336 | $324,404 | 0.07% |
| 47 | ATRECA INC | 04965G109 | 262,827 | $299,623 | 0.06% |
| 48 | AEGLEA BIOTHERAPEUTICS INC | 00773J103 | 883,720 | $256,279 | 0.05% |
| 49 | SCIENCE 37 HOLDINGS INC | 808644108 | 900,000 | $253,440 | 0.05% |
| 50 | KALA PHARMACEUTICALS INC | KALA | 12,024 | $180,961 | 0.04% |
| 51 | SURROZEN INC | SRZNW | 300,000 | $180,600 | 0.04% |
| 52 | NOVAVAX INC | NVAX | 21,244 | $147,221 | 0.03% |
| 53 | KRONOS BIO INC | 50107A104 | 78,131 | $114,071 | 0.02% |
| 54 | NGM BIOPHARMACEUTICALS INC | 62921N105 | 13,669 | $55,770 | 0.01% |
| 55 | NUVATION BIO INC | NUVB | 133,333 | $16,000 | 0.00% |
| 56 | SURROZEN INC | SRZNW | 99,999 | $10,000 | 0.00% |